First Manhattan’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

First Manhattan’s Portfolio AST Stock Details AST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-133	Closed	–	–	1518
2018 Q4	$0	Hold	133	–	–	﹤0.01%	1510
2018 Q3	$0	Hold	133	–	–	﹤0.01%	1487
2018 Q2	$0	Hold	133	–	–	﹤0.01%	1479
2018 Q1	$0	Hold	133	–	–	﹤0.01%	1542
2017 Q4	$0	Hold	133	–	–	﹤0.01%	1580
2017 Q3	$0	Hold	133	–	–	﹤0.01%	1563
2017 Q2	$0	Hold	133	–	–	﹤0.01%	1532
2017 Q1	$0	Hold	133	–	–	﹤0.01%	1511
2016 Q4	$0	Hold	133	–	–	﹤0.01%	1517
2016 Q3	$0	Hold	133	–	–	﹤0.01%	1541
2016 Q2	$0	Hold	133	–	–	﹤0.01%	1593
2016 Q1	$0	Hold	133	–	–	﹤0.01%	1531
2015 Q4	$0	Hold	133	–	–	﹤0.01%	1570
2015 Q3	$0	Hold	133	–	–	﹤0.01%	1555
2015 Q2	$0	Hold	133	–	–	﹤0.01%	1564
2015 Q1	$0	Hold	133	–	–	﹤0.01%	1592
2014 Q4	$0	Buy	+133	New	+$535	﹤0.01%	1609

First Manhattan's AST Position: Q1 2019 in Review

First Manhattan sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q1 2019, closing a stake of 133 shares.

First Manhattan first reported a position in AST in Q4 2014 and held it in 17 quarters. The position peaked at $0 in Q4 2018. 0 funds tracked by Wall St. Rank hold AST as of Q1 2019.

First Manhattan reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q1 2019 after selling out during the quarter.
First Manhattan sold 133 Asterias Biotherapeutics Inc. Series A shares in Q1 2019.
First Manhattan first reported a position in Asterias Biotherapeutics Inc. Series A in Q4 2014 and held it in 17 quarters.
First Manhattan's Asterias Biotherapeutics Inc. Series A position peaked at $0 in Q4 2018.
0 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q1 2019.

Based on First Manhattan's 13F filing for Q1 2019, filed 12 Apr 2019.